French study reveals nirsevimab’s protection against RSV wanes after first year

A nationwide French study shows that while nirsevimab provides strong protection against RSV-related hospital admissions during the initial season, its effectiveness diminishes in the second year, prompting questions about ongoing immunity and vaccination strategies. A nationwide French study published in…















